An enhanced isothermal amplification assay for viral detection.

Abstract

Rapid, inexpensive, robust diagnostics are essential to control the spread of infectious diseases. Current state of the art diagnostics are highly sensitive and specific, but slow, and require expensive equipment. Here we report the development of a molecular diagnostic test for SARS-CoV-2 based on an enhanced recombinase polymerase amplification (eRPA) reaction. eRPA has a detection limit on patient samples down to 5 viral copies, requires minimal instrumentation, and is highly scalable and inexpensive. eRPA does not cross-react with other common coronaviruses, does not require RNA purification, and takes ~45 min from sample collection to results. eRPA represents a first step toward at-home SARS-CoV-2 detection and can be adapted to future viruses within days of genomic sequence availability.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1038/s41467-020-19258-y

Publication Info

Qian, Jason, Sarah A Boswell, Christopher Chidley, Zhi-Xiang Lu, Mary E Pettit, Benjamin L Gaudio, Jesse M Fajnzylber, Ryan T Ingram, et al. (2020). An enhanced isothermal amplification assay for viral detection. Nature communications, 11(1). p. 5920. 10.1038/s41467-020-19258-y Retrieved from https://hdl.handle.net/10161/31263.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.